Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Department of Pharmacology is recognised as one of the leading departments in the field in the world. To take advantage of increased opportunities in biology and of novel technologies the Head of Department has established a Strategic Advisory Board whose role will be to provide vision and advice for research and teaching, and for interacting across the University and with the public.

Professor Emeritus A David Smith FMedSci (former holder of the Chair for 21 years) has agreed to chair the new Board and he will invite a number of external experts to join the Board. David looks forward to meeting each member of staff in person to hear about the opportunities in their research, to discuss their future plans and to receive suggestions.

Nigel Emptage (Head of Department)

David Smith (Chair, Strategic Advisory Board

Similar stories

International collaboration by Potter group uncovers vital element in regulation of Na⁺/K⁺- ATPase-α1

Department

An international collaboration of the Potter Group with Solomon Snyder’s Group in the USA and with Chinese and German colleagues has uncovered the myo-inositol polyphosphate pyrophosphate 5-InsP7 as a regulator of the Na⁺/K⁺- ATPase-α1

Professor Angela Russell receives 2021 Harrington UK Rare Disease Scholar Award

Department Russell Group

Angela Russell, Professor of Medicinal Chemistry in the Oxford Departments of Pharmacology and Chemistry, has been announced as one of the five recipients of the inaugural UK Rare Disease Scholar Award, presented by the Harrington Discovery Institute (HDI).

Professor Fran Platt appointed as new Head of Department of Pharmacology

Department

Professor Fran Platt has been appointed as the new Head of Department for Pharmacology at the University of Oxford. Fran took up her new post with effect from 1 June 2020 and will serve for an initial period of five years.

The Department mourns the loss of three greats in neuropharmacology

Department

This summer three of the world’s most distinguished neurochemists died; each was a member of the Department during their outstanding scientific careers.

Professor Fran Platt secures £1M funding over two years for vital Parkinson's Disease research, in collaboration with Pfizer

Department

There is an increasing body of genetic and biochemical evidence that points toward lysosomal dysfunction as a risk factor for developing age-related neurodegenerative disorders, including Parkinson’s disease (PD).

New Galione group paper explores the role for early Ca2+ signals in phagocytosis

Department

The Galione Lab has a paper published in The EMBO Journal showing that local Ca2+‐nanodomains formed by two‐pore channels (TPCs) on endo-lysosomes are shown to drive phagocytosis in macrophages. Moreover, different endo-lysosomal Ca2+ channels do different jobs at phagocytosis (extreme compartmentation).